[1]祝　斐　陈谦学.CHST2在胶质瘤中的表达及临床意义[J].中国临床神经外科杂志,2021,26(06):429-433.[doi:10.13798/j.issn.1009-153X.2021.06.008]
　ZHU fei,CHEN Qian-xue..Expression of CHST2 in human glioma tissues and its clinical significance based on bioinformatics analysis[J].,2021,26(06):429-433.[doi:10.13798/j.issn.1009-153X.2021.06.008]
点击复制

CHST2在胶质瘤中的表达及临床意义()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
26
期数:
2021年06期
页码:
429-433
栏目:
论著
出版日期:
2021-06-25

文章信息/Info

Title:
Expression of CHST2 in human glioma tissues and its clinical significance based on bioinformatics analysis
文章编号:
1009-153X（2021）06-0429-05
作者:
祝　斐　陈谦学
作者单位：332000 江西九江，解放军庐山康复疗养中心神经外科（祝　斐）；430060 武汉，武汉大学人民医院神经外科（陈谦学）
Author(s):
ZHU fei1;  CHEN Qian-xue2.
1. Department of Neurosurgery, Lushan Rehabilitation and Recuperation Center, PLA, Jiujiang 332000,China; 2. Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China
关键词:
胶质瘤; 糖磺基转移酶2（CHST2）; 预后; 化疗; 免疫细胞浸润; 基因表达
Keywords:
Glioma;  Carbohydrate sulfotransferase 2 (CHST2);  Prognosis;  Chemotherapy;  Immune cell infiltration
分类号:
R 739.41; Q 786
DOI:
10.13798/j.issn.1009-153X.2021.06.008
文献标志码:
A
摘要:
目的 探讨糖磺基转移酶2（CHST2）在人脑胶质瘤中的表达情况及其临床意义。方法 从Gliovis在线网站获取TCGA、CGGA、Rembrandt数据集，分析CHST2表达水平与胶质瘤病理特征、生存预后、免疫细胞浸润的关系。结果 胶质瘤母细胞瘤（GBM）组织CHST2表达水平较低级别胶质瘤（LGG）明显增高（P<0.05），异柠檬酸脱氢酶（IDH）突变型胶质瘤CHST2表达水平较野生型明显增高（P<0.05），1p19q未共缺失胶质瘤CHST2表达水平较未缺失胶质瘤明显增高（P<0.05）。胶质瘤、GBM和LGG病人，O6-甲基鸟嘌呤-DNA甲基转移酶（MGMT）启动子甲基化的GBM和LGG病人，以及仅进行化疗的GBM和LGG病人，CHST2高表达组生存时间均显著低于低表达组（P<0.05）。GBM和LGG组织CHST2表达水平与巨噬细胞和树突状细胞的浸润程度呈正相关（P<0.05）。结论 CHST2表达水平与胶质瘤病人生存预后、化疗反应和免疫细胞浸润密切相关。
Abstract:
Objective To study the expression of carbohydrate sulfotransferase 2 (CHST2) gene in human glioma tissues and its potential clinical significance. Methods The gene expression data of CHST2 in TCGA, CGGA, Rembrandt datasets were obtained from Gliovis online website. An analysis was performed on the relationship between CHST2 expression level and glioma pathological characteristics, survival prognosis, and immune cell infiltration. Results The expression level of CHST2 in glioblastoma (GBM) tissues was significantly higher than that of the low-grade glioma (LGG; P<0.05). The expression level of CHST2 in isocitrate dehydrogenase (IDH) mutant glioma was significantly higher than that of IDH wide-type glioma (P<0.05). The expression level of CHST2 in gliomas with co-deletion of 1p19q was significantly higher than that of gliomas without co-deletion of 1p19q (P<0.05). For patients with glioma, GBM or LGG, GBM and LGG patients with methylation on the O6-methylguanine-DNA methyltransferase (MGMT) promoter, and GBM and LGG patients undergoing simple chemotherapy, the survival time in the CHST2 high expression group was significantly lower than that of the CHST2 low expression group (P<0.05). The expression level of CHST2 in GBM and LGG tissues was positively correlated with the degree of infiltration of macrophages and dendritic cells (P<0.05). Conclusions The expression level of CHST2 in glioma tissues is closely related to the survival prognosis, chemotherapy response and immune cell infiltration in patients with glioma.

参考文献/References:

[1] Han MZ, Xu R, Xu YY, et al. TAGLN2 is a candidate prog-nostic biomarker promoting tumorigenesis in human gliomas[J]. J Exp Clin Cancer Res, 2017, 36(1): 155-163.
[2] 陆　正，刘小江，管　诚，等. Hax-1对胶质瘤细胞增殖、迁移和侵袭的作用[J]. 中国临床神经外科杂志，2021，26（2）：101-105.
[3] 王睿健，张文超，尹　涛. CREPT在人脑胶质母细胞瘤组织中的表达及其与病人预后的关系[J]. 中国临床神经外科杂志，2021，26（1）：20-22.
[4] 孙青青，任洪波，牛国栋. lncRNA SNHG16在人脑胶质瘤组织中的表达及其与病人预后的关系[J]. 中国临床神经外科杂志，2020，25（12）：831-833.
[5] Chen X, Yang TT, Qiu XC, et al. Gene expression profiles of human osteosarcoma cell sublines with different pulmonary metastatic potentials [J]. Cancer Biol Ther, 2011, 11(2): 287-292.
[6] Bowman RL, Wang QH, Carro A, et al. GlioVis data portal for visualization and analysis of brain tumor expression datasets [J]. Neuro Oncol, 2017, 19(1): 139-141.
[7] Li T, Fan J, Wang B, et al. TIMER: a web server for com-prehensive analysis of tumor-infiltrating immune cells [J]. Cancer Res, 2017, 77(21): e108-e110.
[8] Gusyatiner O, Hegi ME. Glioma epigenetics: from subclas-sification to novel treatment options [J]. Semin Cancer Biol, 2018, 51: 50-58.
[9] McNamara MG, Jiang H, Lim-Fat MJ, et al. Treatment out-comes in 1p19q co-deleted/partially deleted gliomas [J]. Can J Neurol Sci, 2017, 44(3): 288-294.
[10] Liu J, Gao L, Zhan N, et al. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma [J]. J Exp Clin Cancer Res, 2020, 39(1):137-148.
[11] Wu L, Bernal GM, Cahill KE, et al. BCL3 expression pro-motes resistance to alkylating chemotherapy in gliomas [J]. Sci Transl Med, 2018, 10(448): 135-146.
[12] Zhong QY, Fan EX, Feng GY, et al. A gene expression-based study on immune cell subtypes and glioma prognosis [J]. BMC Cancer, 2019, 19(1): 1116-1125.

相似文献/References:

[1]常英男　王　策　赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
　CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(06):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛　克　陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许　耿　路俊锋　杨　忠　施建斌　吴秋月　王　烨　庄冬晓　吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
　XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰　陈银生　赛　克　张湘衡　柯　超　杨群英　牟永告　许海雄　陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
　LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波　杨宇焦　张　逵　范润金　张　渊　杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性 癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
　YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚　成于思　王　辉　汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞 增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
　HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林　雨　张　恺　李　帅　杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明　徐成仕　王泽芬　曹长军　李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
　DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(06):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生　田道锋　张申起　陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
　PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(06):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯　驰　郭双毅　程龙海　罗　杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
　FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(06):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]

备注/Memo

备注/Memo:
通讯作者：陈谦学，E-mail：chenqx666@whu.edu.cn
更新日期/Last Update: 2021-06-25